JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

Search

Quidel Corp

Ouvert

11.95 -1.81

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.71

Max

12.29

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+78.34% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-483M

726M

Ouverture précédente

13.76

Clôture précédente

11.95

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

27 avr. 2026, 23:15 UTC

Principaux Événements d'Actualité

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 avr. 2026, 23:08 UTC

Résultats
Principaux Mouvements du Marché

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 avr. 2026, 23:58 UTC

Résultats

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 avr. 2026, 23:58 UTC

Résultats

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 avr. 2026, 23:56 UTC

Résultats

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 avr. 2026, 23:56 UTC

Résultats

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 avr. 2026, 23:48 UTC

Market Talk

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 avr. 2026, 23:42 UTC

Market Talk

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 avr. 2026, 23:34 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 avr. 2026, 23:30 UTC

Market Talk

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 avr. 2026, 23:08 UTC

Market Talk

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 avr. 2026, 23:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 avr. 2026, 23:02 UTC

Market Talk

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 avr. 2026, 22:42 UTC

Market Talk

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 avr. 2026, 22:10 UTC

Résultats

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 avr. 2026, 22:09 UTC

Résultats

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 avr. 2026, 22:09 UTC

Résultats

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 avr. 2026, 22:09 UTC

Résultats

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 avr. 2026, 21:56 UTC

Résultats

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 avr. 2026, 21:55 UTC

Résultats

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 avr. 2026, 21:55 UTC

Résultats

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 avr. 2026, 21:44 UTC

Résultats

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 avr. 2026, 21:43 UTC

Résultats

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 avr. 2026, 21:41 UTC

Résultats

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 avr. 2026, 21:41 UTC

Résultats

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 avr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27 avr. 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

27 avr. 2026, 20:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Financial Services Roundup: Market Talk

27 avr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27 avr. 2026, 20:39 UTC

Résultats

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

78.34% hausse

Prévisions sur 12 Mois

Moyen 20.67 USD  78.34%

Haut 30 USD

Bas 15 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat